| Literature DB >> 21139689 |
R Gupta1, J Chen, O P Srivastava.
Abstract
PURPOSE: The purpn>ose of the study was to determine whether the autodegradation ofEntities:
Mesh:
Substances:
Year: 2010 PMID: 21139689 PMCID: PMC2994418
Source DB: PubMed Journal: Mol Vis ISSN: 1090-0535 Impact factor: 2.367
Figure 1Purification of recombinant βA3-crystallin by the nickel-affinity column chromatographic method. During purification of βA3-crystallin from the soluble protein fraction of the E. coli cell lysate, the bound proteins were eluted using 250 mM imidazole, and each fraction was analyzed using a 15% polyacrylamide gel using the SDS–PAGE method. Fractions (lanes 1 to 9) containing the single major protein band of βA3-crystallin were pooled, dialyzed, and used for further experiments. Circled bands 1, 2, and 3 were excised from gels, trypsin-digested and analyzed by quadruple ion trap (Q-TRAP) mass spectrometric method. The analysis identified these circled species (1, 2, and 3) as βA3-crystallin suggesting that the parent crystallin was partially degraded to produce two minor crystallin fragments during purification.
Figure 2Activation of protease activity in recombinant βA3-crystallin following treatment with sodium deoxycholate or CHAPS. A: The βA3-crystallin preparations (200 μg), treated with sodium deoxycholate or CHAPS, showed protease activity after HPLC fractionation whereas no activity was observed in the detergent-untreated crystallin fraction. B: On SDS–PAGE analysis of the column fractions containing protease activity, two species of 22 and 27 kDa were observed with an absence of the parent 31 kDa βA3-crystallin species. Results suggested a degradation of βA3-crystallin upon activation of its protease activity.
Figure 3Assay of protease activity in the βA3-crystallin following treatment with CHAPS or Triton X-100. Following treatment of βA3-crystallin preparation (50 μg) with either CHAPS or Triton X-100 and incubation with BAPNA as a substrate, only the CHAPS-treated crystallin exhibited protease activity. The protease activity increased during incubation for 24 h at 37 °C as indicated by the release of p-nitroaniline (yellow) from BAPNA, which was monitored at 405 nm.
Figure 4Signature truncation of βA3-crystallin upon incubation with CHAPS. Upon incubation of βA3-crystallin (50 μg) with CHAPS for 24 h at 37 °C in the presence of BAPNA, an increase in the protease activity was accompanied with autodegradation of the crystallin. Lane 1: 0 h incubation and lane 2: 24 h incubation of the crystallin alone without CHAPS; lanes 3 [0 h] and 4 [24 h]) incubation with CHAPS; lanes 5 (0 h) and 6 (24 h) incubation with Triton X-100; lane 7: incubation with CHAPS plus BAPNA, and lane 8: incubation with Triton X-100 and BAPNA. Note the autodegradation of the crystallin to three truncated species (identified as I, II, and III) in the presence of CHAPS but not in the presence of Triton X-100.
Figure 5Inhibition of autodegrdation of βA3-crystalllin by protease inhibitors in the presence of CHAPS. The criterion for inhibition in the study was whether an inhibitor was able to prevent signature autodegradation of βA3-crystallin (50 μg, used with each inhibitor) into the three truncated specific I, II, and III. The inhibitors used in the study are identified at the top of the gel. Only the inhibitors of serine-type proteases such as phenylmethyl sulfonyl fluoride (PMSF, 2 mM, lane 2), aprotinin (25 μg/ml, lane 4) and chymostatin (lane 11) inhibited autodegradation of the crystallin, whereas 4(2-aminoehtyl)-benzene sulfonyl fluoride (2 mM, lane 3) showed partial inhibition of autodegradation. In contrast, the cysteine-protease inhibitors (E-64, 100 μM [lane 5], N-ethylmaleimide, 5 mM [lane 6] and iodoacetamide, 5 mM [lane 7], and metallo-proteinase inhibitors (EDTA, 5 mM [EDTA, lane 8] and ethylene glycotetraacetic acid, 5 mM [EGTA, lane 9] did not stop autodegradation of the crystallin.
Figure 6SDS–PAGE analysis and fluorescence determination to examine binding of FFCK to untruncated βA3-crystallin and its two major truncated products. Lanes 4 and 5 represents βA3-crystallin truncated species, which were recovered following treatment of βA3-crystallin with CHAPS, and were labeled with FFCK. The lanes 6 and 7 represented βA3-crystallin treated with CHAPS but complete degradation of intact crystallin to 22 and 27 kDa species was not allowed to determine if all three species (intact, 22, and 27 kDa species) show labeling with FFCK. The untruncated βA3-crystallin (Coomassie blue stained in lane 7 of A) and its two truncated species of 22 and 27 kDa (Coomassie blue-stained bands in lane 4 and 7 in A) showed binding to FFCK (25 μM, final concentration) as represented by fluorescent bands (lane 4 and 7 in B). The results suggest that because of FFCK binding, the protease active site is present in both untruncated βA3-crystallin and its major truncated species II and III.